Matrix metalloproteinase in mammary gland remodeling-modulation by glycosaminoglycans

Biosci Rep. 1999 Oct;19(5):485-90. doi: 10.1023/a:1020276609159.

Abstract

Mammary gland which undergoes proliferation, differentiation and involution in adult life is a useful model system to study the role of extracellular matrix (ECM) in regulating tissue specific functions. The involution that follows weaning results in the suppression of casein gene expression, collapse of alveolar structures and degradation of basement membrane as evidenced by biochemical analysis of matrix components like proteoglycans and collagen. Differential expression of three different MMPs viz. 130 K, 68 K and 60 K with varying specificity to Col IV of basement membrane and Col I of stroma, their selective inhibition by TIMP and proteoglycans and modulation by estrogen highlight the importance of these in the remodeling of the ECM in the mammary gland. The inhibition of these MMPs by glycosaminoglycans, particularly CS and change in the concentration of CS at different stages of mammary gland development suggests the existence of a novel mechanism for the regulation of the activity of MMPs at extracellular sites.

MeSH terms

  • Animals
  • Extracellular Matrix / enzymology*
  • Female
  • Glycosaminoglycans / metabolism
  • Glycosaminoglycans / pharmacology*
  • In Vitro Techniques
  • Lactation / physiology
  • Mammary Glands, Animal / growth & development
  • Mammary Glands, Animal / metabolism*
  • Matrix Metalloproteinase Inhibitors
  • Matrix Metalloproteinases / metabolism*
  • Rats
  • Tissue Inhibitor of Metalloproteinase-2 / metabolism

Substances

  • Glycosaminoglycans
  • Matrix Metalloproteinase Inhibitors
  • Tissue Inhibitor of Metalloproteinase-2
  • Matrix Metalloproteinases